Inside the stealthy startup that pitched brainless human clones | MIT Technology Review
technologyreview.com · 5,126 words · saved by 1 readers
The ultimate plan to live forever is a brand new body.
Inside the stealthy startup that pitched brainless human clones | MIT Technology Review Skip to Content After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing. In an interview with Wired , R3 listed three investors: billionaire Tim Draper, the Singapore-based fund Immortal Dragons, and life-extension investors LongGame Ventures. But there is more to the story. And R3 doesn’t want that story told. MIT
saved by
related reading
- Bottlenecks of Aging - Amaranth Foundationamaranth.foundation
- Why Cryonics Makes Sense — Wait But Whywaitbutwhy.com
- Conception: How Silicon Valley hatched a plan to turn blood into lab-made human eggs | MIT Technology Reviewtechnologyreview.com
- Meet Altos Labs, Silicon Valley's latest wild bet on living forever | MIT Technology Reviewtechnologyreview.com
- Sam Altman invested $180 million into a company trying to delay death | MIT Technology Reviewtechnologyreview.com
- Why Don’t Billionaires Invest In Longevity?nfx.com
- The longevity tech market map: 64 startups racing to defy deathcbinsights.com
- Anti-Aging: State of the Art — LessWronglesswrong.com
- Home - Tomorrow Biotomorrow.bio
- Nintil - Aging is already solved in vitro. What comes next?nintil.com
- The Biosingularity Alignment Problem Seems Harder than AI Alignmentberen.io
- The Longevity Land Grab | Will Ventureswillventures.com